Official recall notice

FDA DrugClass IINotable

FDA Recall: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Conta

Recall date
2026-09-09
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

CGMP Deviations

Product description

CGMP Deviations

Affected products

Lot # NC194068, Exp Date: 10/29/2027.

Verify with the official notice →
Share:

Related Recalls

2026-09-09 · FDA_DRUG
FDA Recall: Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Co
Baxter Healthcare Corporation
2026-09-09 · FDA_DRUG
FDA Recall: Vasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL Single-Dos
Baxter Healthcare Corporation
2026-09-09 · FDA_DRUG
FDA Recall: Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 10
Baxter Healthcare Corporation
2026-09-09 · FDA_DRUG
FDA Recall: Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container,
Baxter Healthcare Corporation